mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.14 |
0.03 |